Pathologists, Labs Differ On Hep C Nucleic Acid Test Payment Methodology
This article was originally published in The Gray Sheet
Executive Summary
Nucleic acid testing for hepatitis C virus should be reimbursed by "cross-walking" the new CPT code for HCV NAT to the code for HIV-1 NAT, according to the American Clinical Laboratory Association.
You may also be interested in...
HCFA Relying Increasingly On "Cross-Walking" Codes For New Lab Tests
As many as 16 of the 56 new CPT codes that HCFA "cross-walked" to existing codes on its Medicare clinical laboratory fee schedule in 2001 may not meet basic levels of clinical similarity.
HCFA Clinical Lab Test Payments Should Defer To NLA Levels, IoM Says
Medicare outpatient clinical laboratory payments should be set at the current national limitation amounts (NLAs), pending development of a resource-based relative value scale, the Institute of Medicine advises in a recent report.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.